(9R)-9-chloro-11-17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10-13-16-trimethyl-6-7-8-11-12-14-15-16-octahydrocyclopenta[a]phenanthren-3-one and Aspergillosis

(9R)-9-chloro-11-17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10-13-16-trimethyl-6-7-8-11-12-14-15-16-octahydrocyclopenta[a]phenanthren-3-one has been researched along with Aspergillosis* in 4 studies

Trials

2 trial(s) available for (9R)-9-chloro-11-17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10-13-16-trimethyl-6-7-8-11-12-14-15-16-octahydrocyclopenta[a]phenanthren-3-one and Aspergillosis

Article	Year
Management of allergic fungal sinusitis with postoperative oral and nasal steroids: a controlled study. Ear, nose, & throat journal, 2009, Volume: 88, Issue:4 In patients with allergic fungal sinusitis, the mainstay of treatment remains surgical removal of allergic mucin and fungal debris. But as a single modality, surgery is associated with high rates of recurrence, so a number of adjunctive medical modalities have been tried, including postoperative corticosteroid therapy. We conducted a study of 63 patients with allergic fungal sinusitis who underwent endoscopic sinus surgery with or without postoperative steroid therapy. A group of 30 patients who had been treated prior to January 2000 had undergone surgery only; their cases were reviewed retrospectively, and they served as historical controls. Another 33 patients who were treated after June 2000 underwent surgery plus oral and nasal steroid therapy. All patients were followed for a minimum of 2 years. Recurrences were seen in 50.0% (15/30) of the no-steroid group and 15.2% (5/33) of the steroid group-a statistically significant difference (p = 0.008). The results of our study strongly support the use of steroids to control allergic fungal sinusitis and prevent its recurrence, and we recommend further study to identify the optimal dosage and duration of therapy. Topics: Administration, Intranasal; Adult; Anti-Inflammatory Agents; Antifungal Agents; Aspergillosis; Beclomethasone; Combined Modality Therapy; Endoscopy; Female; Humans; Hyperplasia; Male; Mucins; Nasal Mucosa; Postoperative Care; Prednisone; Prospective Studies; Retrospective Studies; Rhinitis, Allergic, Perennial; Risk Factors; Sinusitis	2009
Beclomethasone dipropionate aerosol in long-term treatment of perennial and seasonal asthma in children and adults: a report of five-and-half years' experience in 600 asthmatic patients. British journal of clinical pharmacology, 1977, Volume: 4 Suppl 3 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aerosols; Aged; Aspergillosis; Asthma; Beclomethasone; Candidiasis; Child; Child, Preschool; Chronic Disease; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Pregnancy; Seasons; Substance-Related Disorders; Time Factors	1977

Article

Year

Management of allergic fungal sinusitis with postoperative oral and nasal steroids: a controlled study.

Ear, nose, & throat journal, 2009, Volume: 88, Issue:4

In patients with allergic fungal sinusitis, the mainstay of treatment remains surgical removal of allergic mucin and fungal debris. But as a single modality, surgery is associated with high rates of recurrence, so a number of adjunctive medical modalities have been tried, including postoperative corticosteroid therapy. We conducted a study of 63 patients with allergic fungal sinusitis who underwent endoscopic sinus surgery with or without postoperative steroid therapy. A group of 30 patients who had been treated prior to January 2000 had undergone surgery only; their cases were reviewed retrospectively, and they served as historical controls. Another 33 patients who were treated after June 2000 underwent surgery plus oral and nasal steroid therapy. All patients were followed for a minimum of 2 years. Recurrences were seen in 50.0% (15/30) of the no-steroid group and 15.2% (5/33) of the steroid group-a statistically significant difference (p = 0.008). The results of our study strongly support the use of steroids to control allergic fungal sinusitis and prevent its recurrence, and we recommend further study to identify the optimal dosage and duration of therapy.

Topics: Administration, Intranasal; Adult; Anti-Inflammatory Agents; Antifungal Agents; Aspergillosis; Beclomethasone; Combined Modality Therapy; Endoscopy; Female; Humans; Hyperplasia; Male; Mucins; Nasal Mucosa; Postoperative Care; Prednisone; Prospective Studies; Retrospective Studies; Rhinitis, Allergic, Perennial; Risk Factors; Sinusitis

2009

Beclomethasone dipropionate aerosol in long-term treatment of perennial and seasonal asthma in children and adults: a report of five-and-half years' experience in 600 asthmatic patients.

British journal of clinical pharmacology, 1977, Volume: 4 Suppl 3

Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aerosols; Aged; Aspergillosis; Asthma; Beclomethasone; Candidiasis; Child; Child, Preschool; Chronic Disease; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Pregnancy; Seasons; Substance-Related Disorders; Time Factors

1977

Other Studies

2 other study(ies) available for (9R)-9-chloro-11-17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10-13-16-trimethyl-6-7-8-11-12-14-15-16-octahydrocyclopenta[a]phenanthren-3-one and Aspergillosis

Article	Year
[Obstructive bronchial aspergillosis of favorable course under corticoids in a HIV seropositive patient]. Annales de medecine interne, 1988, Volume: 139, Issue:4 Topics: Adult; Aspergillosis; Aspergillus fumigatus; Beclomethasone; HIV Seropositivity; Humans; Lung Diseases, Fungal; Male; Prednisolone; Time Factors	1988
Bronchopulmonary aspergillosis--treatment with beclomethasone dipropionate. Postgraduate medical journal, 1975, Volume: 51 Suppl 4 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Airway Obstruction; Aspergillosis; Beclomethasone; Bronchodilator Agents; Female; Humans; Male; Methylprednisolone; Middle Aged; Respiratory Function Tests; Respiratory Tract Infections	1975